{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Metabolic Enzyme & Protease > Nafamostat mesylateCAS：82956-11-4
Molecular Formula：C19H17N5O2·2CH4O3S
Molecular Weight：539.58
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：Off-white to light yellow Solid
Qty：
Size：
| CAS | 82956-11-4 |
| Name | Nafamostat mesylate |
| Molecular Formula | C19H17N5O2·2CH4O3S |
| Molecular Weight | 539.58 |
| Solubility | Soluble in DMSO |
| Purity | HPLC≥98% |
| Appearance | Off-white to light yellow Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 692-168-2 |
| MDL | MFCD00941430 |
| SMILES | CS(=O)(O)=O.O=C(OC1=CC=C2C=C(C(N)=N)C=CC2=C1)C3=CC=C(NC(N)=N)C=C3.CS(=O)(O)=O |
| Target Point | Ser/Thr Protease |
| Passage | Metabolic Enzyme&Protease |
| Background | Nafamostat mesylate is a broad-spectrum serine protease inhibitor. Nafamostat mesylate can inhibit blood coagulation and can be used in the research of complement inhibition. Nafamostat mesylate can inhibit the activation of SARS-CoV-2 and can be used for COVID-19 related research. Nafamostat mesylate also attenuates inflammation and apoptosis. |
| Unit | Bottle |
| Specification | 10mg 50mg 100mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
